“…Four tools were developed in the United States (29,31,(33)(34) , four in Great Britain (9,30,32,35) , one in Australia (13) , and one in Iran (24) . All but one of the tools (31) are setting (primary health care (9,32) and hospital care (30) ) or condition-specific. With respect to the condition-specific tools, one addressed mental health (33) , two diabetes (24,29) , two cancer (13,34) , and one clinical genetics (35) .…”